Background: The Unpredictability of Pediatric ITP
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and variable bleeding risk. In children, the disease often resolves spontaneously within a year, but approximately 30% progress to chronic ITP, which poses long-term management challenges. Current predictors for disease chronicity are limited, creating uncertainty in early clinical decision-making.
